Iqirvo savings card: as little as $0 a prescription with commercial insurance

How to pay the least

Ask for the cash price

Iqirvo

We didn’t find one.

Ask your pharmacy for Iqirvo’s cash price, and one or two other pharmacies too.
Iqirvo’s savings card works only with insurance from a job or one you bought.

Free from the maker, if you qualify IPSEN CARES Patient Assistance Program. Patients may be eligible to receive free drug through our Patient Assistance Program if they are experiencing financial hardship and meet financial eligibility criteria Or call 1-866-435-5677.

See if you qualify

Compare every option

Brand nameIqirvo

Authorized genericelafibranor

Regular genericelafibranor

What you’d pay

Cash priceAsk the pharmacy

Not soldThere isn’t one

Not soldNone found

Same as Iqirvo?

The original

–

Brand nameThe maker’s card

Iqirvo Copay Assistance Program (IPSEN CARES)

Savings card from Ipsen

No insuranceNeeds insuranceNo cash price listed.

Insurance · as little as $0 a prescription

In the maker’s words

“If you have been prescribed Iqirvo and you have commercial (private) insurance, you may be eligible to receive copay assistance and pay as little as $0 per prescription for Iqirvo.”

From the maker’s offer on ipsencares.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Maker’s card or discount card?

A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s card above. You can usually use one or the other on a fill, not both.

Authorized genericNot sold

There isn’t one. An authorized generic is Iqirvo itself, from the same company, sold without the brand name, and usually for less. For now Iqirvo is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

We didn’t find one. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

Primary biliary cholangitis (PBC, a liver disease)

What the FDA label says

IQIRVO is a peroxisome proliferator-activated receptor (PPAR) agonist indicated for the treatment of primary biliary cholangitis (PBC) in combination with ursodeoxycholic acid (UDCA) in adults who have an inadequate response to UDCA, or as monotherapy in patients unable to tolerate UDCA.

This indication is approved under accelerated approval based on reduction of alkaline phosphatase (ALP). Improvement in survival or prevention of liver decompensation events have not been demonstrated. Continued approval for this indication may be contingent upon verification and description of clinical benefit in confirmatory trial(s).

Limitations of Use

Use of IQIRVO is not recommended in patients who have or develop decompensated cirrhosis (e.g., ascites, variceal bleeding, hepatic encephalopathy).

Source: the FDA label for Iqirvo (Ipsen Biopharmaceuticals, Inc.), August 11, 2026. Full label on DailyMed

Good to know

“Commercial insurance” means a plan from a job, from the marketplace, or one you buy yourself. A retiree plan that’s part of Medicare counts as Medicare. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.
Most cards need a sign-up on the maker’s site, and many work only if your plan covers the drug. Then give the card’s details to your pharmacy.
Don’t stop or change a medicine without talking to your pharmacist or prescriber.

Prices checked November 2, 2026. Prices change: confirm with the pharmacy before you fill. drugalt.com/drug/iqirvo/